Figure 3

Hospitalization characteristics and pharmacotherapy in COVID-19 patients. (a) Hospitalization duration of severe and critical patients stratified by survival. (b) Types of oxygen therapies employed in hospitalized patients. (c) Cumulative hazard of death versus days of hospitalization according to the type of oxygen therapy. (d) Cases and fatality rate of complications from COVID-19.